Nigeria’s drug regulatory authority has issued an urgent public alert following the recall of specific batches of Citro-Soda Regular antacid in South Africa due to potential contamination at the manufacturing facility. The National Agency for Food and Drug Administration and Control (NAFDAC) was notified by the South African Health Products Regulatory Authority (SAPHRA) of contamination risks identified at the Adcock Ingram Clayville facility in Johannesburg.
Manufacturing facility contamination prompts immediate recall
The recall affects specific batches of Citro-Soda Regular, an effervescent urinary alkalinizer and gastric antacid commonly used for treating heartburn and indigestion. According to SAPHRA, the contamination risk was identified during routine facility inspections at the Adcock Ingram Clayville manufacturing plant in Johannesburg.
NAFDAC’s alert, designated as Public Alert No. 025/2026, advises Nigerian consumers and healthcare providers to exercise caution regarding the affected product. The agency emphasizes that while the recall is currently limited to South Africa, Nigerian consumers who may have purchased the product during travel or through import channels should be aware of the safety concerns.
Nigerian regulatory response and consumer guidance
The Nigerian regulatory authority is working closely with World Health Organization protocols for international drug safety alerts. NAFDAC has strengthened surveillance of antacid products entering Nigerian markets through both official and unofficial channels.
Healthcare professionals are advised to report any adverse reactions related to Citro-Soda Regular to NAFDAC’s pharmacovigilance system. The agency has also enhanced border screening procedures for pharmaceutical products originating from the affected South African facility. Consumer safety remains the primary concern as regulatory authorities coordinate their response across the region.
Multiple batches of Citro-Soda Regular have been recalled in South Africa due to contamination risks identified at the Adcock Ingram manufacturing facility
— NAFDAC Public Alert No. 025/2026, National Agency for Food and Drug Administration and Control (2026)
Key takeaways
- NAFDAC issued urgent alert following South African recall of Citro-Soda Regular batches
- Contamination risk identified at Adcock Ingram Clayville manufacturing facility in Johannesburg
- Nigerian consumers advised to exercise caution with the affected antacid product
- Enhanced surveillance and border screening implemented for pharmaceutical imports
Frequently asked questions
What should Nigerian consumers do if they have Citro-Soda Regular?
Consumers should check batch numbers against the recalled list and discontinue use immediately if affected. Contact NAFDAC or your healthcare provider for guidance on safe disposal and alternative treatments.
Is Citro-Soda Regular commonly available in Nigeria?
While not widely distributed through official channels in Nigeria, some consumers may have obtained the product during travel to South Africa or through informal import networks.
How does NAFDAC monitor international drug recalls?
NAFDAC maintains active communication with international regulatory authorities like SAPHRA and follows WHO protocols for cross-border pharmaceutical safety alerts to protect Nigerian consumers.
The coordinated response between NAFDAC and South African authorities demonstrates the importance of international regulatory cooperation in protecting consumer safety. As global pharmaceutical supply chains become increasingly interconnected, such collaborative monitoring systems will remain essential for rapid identification and management of product safety risks across borders.
